These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25151619)

  • 21. Latency to startle is increased in the 5xFAD mouse model of Alzheimer’s disease.
    Story D; Chan E; Munro N; Rossignol J; Dunbar GL
    Behav Brain Res; 2019 Feb; 359():823-827. PubMed ID: 30055208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
    Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B
    Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M; Ricobaraza A; Frechilla D; Franco R; Pérez-Mediavilla A; Garcia-Osta A
    J Alzheimers Dis; 2012; 28(3):567-78. PubMed ID: 22045482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.
    Koppel J; Acker C; Davies P; Lopez OL; Jimenez H; Azose M; Greenwald BS; Murray PS; Kirkwood CM; Kofler J; Sweet RA
    Neurobiol Aging; 2014 Sep; 35(9):2021-8. PubMed ID: 24731519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.
    Lee S; Lemere CA; Frost JL; Shea TB
    J Alzheimers Dis; 2012; 28(2):423-31. PubMed ID: 22045486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
    Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
    J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
    Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
    Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.